To view or add a comment, sign in Top 10 diabetes drugs by sales TOP 2: Jardiance (Empagliflozin) 2023 Sales: $10.73 Billion Company: Boehringer Ingelheim/Eli Lilly FDA First Approval: August 1, 2014 Indications: Type 2 diabetes, chronic heart failure, chronic kidney disease In 2023, Jardiance accounted for 28.8% of Boehringer Ingelheim's net sales, making it the top-performing product
liraglutide, semaglutide, or exenutide)
If a remedy requires a prescription or invasive step, discuss risks and benefits with a clinician first
The scale can remain stable while dramatic improvements occur in the ratio of muscle to fat, making alternative tracking methods essential for accurate assessment
However, if you have specific sensitivities or a history of respiratory challenges, you should be particularly cautious with inhaled formats of glutathione, which can sometimes cause irritation in the airways